Evaluation of mutagenic and antimutagenic activities of α-bisabolol in the Salmonella/microsome assay

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 585, Issue 1-2, 2005, Pages 105-112

  Gomes Carneiro, M R ^a   Dias, Daniela M M ^a   De Oliveira, A C A X ^a   Paumgartten, Francisco J R ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Bisabolol; Ames test; Antimutagenicity; Mutagenicity; Salmonella typhimurium; Sesquiterpenes

Indexed keywords

2 AMINOANTHRACENE; 2 FLUORENYLAMINE; 2 NITROFLUORENE; 4 NITROQUINOLINE 1 OXIDE; AFLATOXIN B1; BENZO[A]PYRENE; BISABOLOL; CYCLOPHOSPHAMIDE; CYTOCHROME P450 1A1; CYTOCHROME P450 2B1; ETHOXYRESORUFIN DEETHYLASE; FARMANGUINHOS; MUTAGENIC AGENT; PENTOXYRESORUFIN DEALKYLASE; PHENYLENEDIAMINE; PROMUTAGEN; SODIUM AZIDE;

AMES TEST; ARTICLE; BACTERIAL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; LIVER MICROSOME; MUTAGENIC ACTIVITY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM;

ANIMALS; ANTIMUTAGENIC AGENTS; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2B1; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; MICROSOMES, LIVER; MUTAGENICITY TESTS; RATS; RATS, WISTAR; SALMONELLA TYPHIMURIUM; SESQUITERPENES;

ANTHEMIS; MATRICARIA CHAMOMILLA; SALMONELLA; SALMONELLA TYPHIMURIUM;

EID: 22144455690     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2005.04.007     Document Type: Article

References (22)

1. S. Harbersang, F. Leuschner, O. Isaac, and K. Thiemer Pharmacological studies with compounds of chamomile: 4. Toxicity of (levo)-alpha-bisabolol Planta Med. 37 1979 115 123
2. R. Schimitz (-)-Alpha-bisabolol in Anica amplexicaulis and Arnica chamissonis Arch. Pharm. 312 1979 551 552
3. C. Jequier, G. Nicollier, R. Tabacchi, and J. Garnero Constituents of essential oil of Salvia stenophylla Riv. Ital. Essenze, Profumi, Piante Off., Aromi, Saponi, Cosmet., Aerosol 62 1980 121 122
4. O. Sticher Plant mono-,di- and sesquiterpenoids with pharmacological or therapeutical activity H. Wagner P. Wolff New Natural Products and Plants with Pharmacological, Biological or Therapeutic Activity 1977 Springer-Verlag Berlin 137 176
5. V. Jakovlev, and A. von Schlichtegroll Zur entzündungshemmeden Wirkung von (-)-α-Bisabolol, einem wesentlichen Bestandteil des Kamillenöls Arzneimittelforschung 19 1969 615 616
6. O. Isaac, and K. Thiemer Biochemische Untersuchungen von Kamilleinhaltsstoffen. III. In-vitro-Versuche über die antipeptische Wirkung des (-)-α-Bisabolols Arzneimittelforschung 25 1975 1352 1354
7. M. Moreno-Fernandes, N. Alvares-Pereira, and L. Gonçalves-Paulo Anti-inflammatory activity of copaiba balsam (Copaifera cearensis, Huber) Rev. Bras. Farm. 73 1992 53 56
8. R. Kadir, and B.W. Barry Alpha-bisabolol, a possible safe penetration-enhancer for dermal and transdermal therapeutics Int. J. Pharm. 70 1991 87 94
9. P.M. Baker, C.C. Fortes, E.G. Fortes, G. Gazzinelli, B. Gilbert, J.N.C. Lopes, J. Pellegrino, T.C.B. Tomassini, and W. Vichnewski Chemoprophylactic agents in schistosomiasis: eremanthine, costunolide, α-cyclostulonide and bisabolol J. Pharm. Pharmac. 24 1972 853 857
10. E. Cavalieri, S. Mariotto, C. Fabrizi, A.C. de-Prati, R. Gottardo, S. Leone, L.V. Berra, G.M. Laura, A.R. Ciampa, and H. Suzuki α-Bisabolol, a nontoxic natural compound, strongly induces apoptosis in glioma cells Biochem. Biophys. Res. Commun. 315 2004 589 594
11. M.R. Gomes-Carneiro, I. Felzenszwalb, and F.J.R. Paumgartten Mutagenicity testing of (±)-camphor, 1,8-cineole, citral, citronellal, (-)-menthol and terpineol with the Salmonella/microsome assay Mutat. Res. 416 1998 129 136
12. D.M. Maron, and B.N. Ames Revised methods for Salmonella mutagenicity test Mutat. Res. 113 1983 173 215
13. A.C.A.X. De-Oliveira, A.A. Fidalgo-Neto, and F.J. Paumgartten In vitro inhibition of liver monooxigenases by β-ionone, 1,8-cineole, (-)-menthol and terpineol Toxicology 135 1999 33 41
14. M.D. Burke, S. Thompsom, R.J. Weaver, C.R. Wolf, and R.T. Mayer Cytochrome P450 specificities of alkoxyresorufin-o-dealkylation in human and rat liver Biochem. Pharmacol. 48 1994 923 936
15. A. Hernández-Ceruelos, E. Madrigal-Bujaidar, and C. de-la-Cruz Inhibitory effects of chamomile essential oil on the sister chromatid exchanges induced by daunorubicin and methyl methanesulfonate in mouse bone marrow Toxicol. Lett. 135 2002 103 110
16. B. Oesch-Bartlomowicz, B. Richter, R. Becker, S. Vogel, P.R. Padma, J.-G. Hengstler, and F. Oesch Camp-dependent phosphorylation of CYP2B1 as a functional switch for cyclophosphamide activation and its hormonal control in vitro and in vivo Int. J. Cancer 94 2001 733 742
17. D.F.V. Lewis P450 substrate specificity and metabolism D.F.V. Lewis Cytochromes P450, Structure, Function and Mechanism 1996 Taylor & Francis Publishers London pp.115-167
18. F.P. Guengerich, W.W. Johnson, T. Shimada, Y.F. Ueng, H. Yamazaki, and S. Langouet Activation and detoxication of aflatoxin B1 Mutat. Res. 402 1998 121 128
19. T.M. Buetler, T.K. Bammler, J.D. Hayes, and D.L. Eaton Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemoprevention Cancer Res. 56 1996 2306 2313
20. T.G. Ha, and N.D. Kim 2-(Allylthio)pyrazine inhibition of aflatoxin B1-induced hepatotoxicity in rats: inhibition of cytochrome P450 2B- and 3A2-mediated bioactivation Res. Commun. Mol. Pathol. Pharmacol. 102 1998 69 78
21. A.C.A.X. De-Oliveira, L.F. Ribeiro-Pinto, and F.J.R. Paumgartten In vitro inhibition of CYP2B1 monooxygenase by β-myrcene and other monoterpenoid compounds Toxicol. Lett. 92 1997 39 46
22. C. Roescheisen, H. Zamith, F. Paumgartten, and G. Speit Influence of beta-myrcene on sister-chromatid exchanges induced by mutagens in V79 and HTC cells Mutat. Res. 264 1991 43 49